Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Raltegravir vs atazanavir/ritonavir plus tenofovir DF and emtricitabine in ART‑naive HIV/HCV coinfected adults
2009-015904-24Phase 4Completed
- Sponsor
- University of Bonn
- Start
- Jul 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of raltegravir in human immunodeficiency virus infection (HIV) and hepatitis C virus infection (2 arms), sponsored by University of Bonn. Started Jul 2010; status: completed.
02
Drugs
raltegravir
03
Conditions
human immunodeficiency virus infection (HIV)hepatitis C virus infection
Beyond the preview
Go deeper on 2009-015904-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-015904-24.